Back to the main directory
Press Release
- Allarity Therapeutics Presents Novel Drug Response Predictor—DRP®—for Daratumumab in Multiple Myeloma at AACR 2025 by GlobeNewsWire
- Esperion to Participate in The Citizens Life Sciences Conference by GlobeNewsWire
- LGI Homes Opens New Section at Popular Second Creek Farm Community in Commerce City, CO by GlobeNewsWire
- Oxford Square Capital Corp. Announces Net Asset Value and Selected Financial Results for the Quarter Ended March 31, 2025 and Declaration of Distributions on Common Stock for the Months Ending July 31, August 31, and September 30, 2025 by GlobeNewsWire
- North American Construction Group Ltd. Announces Pricing of Private Placement Offering of $225 Million Senior Unsecured Notes by GlobeNewsWire
- VYNE Therapeutics Provides Update on VYN202 Program by GlobeNewsWire
- Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711 by GlobeNewsWire
- Genius Group to Release Full Year 2024 Results and Host Investor Webcast on April 30, 2025 by GlobeNewsWire
- SciSparc-Clearmind Collaboration Leads to Filing of International Patent Application for Novel Treatment of Anorexia, Bulimia and other Eating Disorders by GlobeNewsWire
- StepStone Group Closes Fourth Tactical Growth Fund with Over $700 Million in Capital Commitments by GlobeNewsWire
- Harju Maakohus langetas vaheotsuse Tallinna Tehnikaülikooli poolt Tallinna Vee suhtes esitatud hagi osas by GlobeNewsWire
- Cogent Biosciences Presents Four Posters at the American Association for Cancer Research Annual Meeting 2025 and Announces Two New Leaders by GlobeNewsWire
- Huhtamäki Oyj - Johdon liiketoimet (Vauramo) by GlobeNewsWire
- Swiss Properties Invest A/S: Results of the Annual General Meeting by GlobeNewsWire
- Nexxen to Host Inaugural Investor Day on May 22, 2025 by GlobeNewsWire
- BTS Group’s Annual Report 2024 is now available online by GlobeNewsWire
- Pacific Financial Corp Earns $2.4 Million, or $0.24 per Diluted Share for First Quarter 2025; Board of Directors Approves 5% Stock Buyback Plan; Declares Quarterly Cash Dividend of $0.14 per Share by GlobeNewsWire
- Coeptis Therapeutics, Inc. and Z Squared Inc. Announce Merger Agreement by GlobeNewsWire
- Suominen Oyj:n varsinaisen yhtiökokouksen ja hallituksen järjestäytymiskokouksen päätökset by GlobeNewsWire
- Better Choice Company Cancels Previously Announced Stock Dividend by GlobeNewsWire
- Nano Dimension Announces Closing of Markforged Acquisition by GlobeNewsWire
- Umicore - All agenda items approved at the shareholders' meetings by GlobeNewsWire
- Umicore - Alle agendapunten goedgekeurd tijdens de algemene vergaderingen by GlobeNewsWire
- InspireMD to Announce First Quarter 2025 Financial Results by GlobeNewsWire
- Anika to Issue First Quarter 2025 Financial Results on Friday, May 9, 2025 by GlobeNewsWire
- Enviri Corporation to Participate in Upcoming Investor Conferences by GlobeNewsWire
- Guardforce AI to Host Year-End 2024 Financial Results Conference Call on Monday, April 28th at 8:30 A.M. ET by GlobeNewsWire
- Gentex Reports First Quarter 2025 Financial Results by GlobeNewsWire
- TopBuild Achieves 2025 Great Place to Work Certification for Third Consecutive Year by GlobeNewsWire
- Greif Honored as Stevie® Award Winner in 2025 American Business Awards® by GlobeNewsWire
- Acrivon Therapeutics to Reveal the Molecular Mechanisms Driving Strong Single-Agent Activity of ACR-2316, its AP3-Enabled Clinical Stage WEE1/PKMYT1 Inhibitor, at the AACR Annual Meeting 2025 by GlobeNewsWire
- Silicon Motion Confirms Quarterly Dividend by GlobeNewsWire
- Oxbridge / SurancePlus to Attend TOKEN2049 Dubai by GlobeNewsWire
- Crédit Agricole Normandie Seine : Rapport Financier Annuel 2024 (format ESEF) by GlobeNewsWire
- Harju County Court made an interim judgement regarding the claim filed by Tallinn University of Technology against Tallinna Vesi by GlobeNewsWire
- Crédit Agricole Normandie Seine : communiqué financier trimestriel au 31 mars 2025 by GlobeNewsWire
- Huhtamäki Oyj - Managers' Transactions (Vauramo) by GlobeNewsWire
- CERo Therapeutics Holdings, Inc. to Present Poster on Lead Program, CER-1236, at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting by GlobeNewsWire
- Telos Corporation to Announce First Quarter 2025 Financial Results on May 9, 2025 by GlobeNewsWire
- Rush Factory Oyj: Osakevaihdon odotetaan toteutuvan arviolta 28.4.2025 ja kaupankäynnin alkavan arviolta 29.4.2025; päivitys hallituksen kokoonpanoon osakevaihdon jälkeen by GlobeNewsWire
- BTS Group AB:s årsredovisning för 2024 finns tillgänglig på hemsidan by GlobeNewsWire
- Preferred Bank Reports First Quarter Results by GlobeNewsWire
- Decisions taken by Suominen Corporation’s Annual General Meeting and the Board of Directors by GlobeNewsWire
- Keskisuomalainen Oyj:n varsinaisen yhtiökokouksen 2025 ja hallituksen järjestäytymiskokouksen päätökset by GlobeNewsWire
- Better Choice Company Announces Closing of the SRx Health Merger, Name/Symbol Change and Completes $8.8 Million Private Placement Priced Above Last Market Closing Price by GlobeNewsWire
- Pharming Group announces upcoming presentations at the 2025 Annual Meeting of the Clinical Immunology Society (CIS) by GlobeNewsWire
- Umicore - Tous les points de l'ordre du jour approuvés lors des assemblées générales des actionnaires by GlobeNewsWire
- Callan JMB Appoints Former Assistant Commissioner of Chicago Department of Health, Christopher Shields, as Senior Vice President of Emergency Preparedness & Response/Government Affairs by GlobeNewsWire
- Gogo to Report First Quarter 2025 Financial Results on May 9th, 2025 by GlobeNewsWire
- ALX Oncology Reports ASPEN-03 and ASPEN-04 Phase 2 Trials Evaluating Evorpacept with a Checkpoint Inhibitor for the Treatment of Head and Neck Cancers Did Not Meet Primary Endpoints by GlobeNewsWire